BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20854547)

  • 1. When to seek ethical review for a study.
    McCluskey A
    Aust Occup Ther J; 2009 Dec; 56(6):371. PubMed ID: 20854547
    [No Abstract]   [Full Text] [Related]  

  • 2. Institutional review board approval for surveys: why it is necessary.
    Orvis AK; Dellavalle RP
    J Am Acad Dermatol; 2008 Oct; 59(4):718-9. PubMed ID: 18793941
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethical oversight of research in developing countries.
    Kass N; Dawson L; Loyo-Berrios NI
    IRB; 2003; 25(2):1-10. PubMed ID: 12833901
    [No Abstract]   [Full Text] [Related]  

  • 4. Research oversight through new lenses: the consortium to examine clinical research ethics.
    Sugarman J; Eckenwiler LA; Emanuel EJ
    IRB; 2003; 25(1):9-10. PubMed ID: 12833899
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence-based practice of research ethics review?
    Beagan B; McDonald M
    Health Law Rev; 2005; 13(2-3):62-8. PubMed ID: 16459416
    [No Abstract]   [Full Text] [Related]  

  • 6. The conduct of Canadian researchers and institutional review boards regarding substituted consent for research.
    Bravo G; Dubois MF; Paquet M
    IRB; 2004; 26(1):1-8. PubMed ID: 15281211
    [No Abstract]   [Full Text] [Related]  

  • 7. The task for ethics review: should research ethics boards address an approach or a paradigm?
    Nelson CH; McPherson DH
    NCEHR Commun; 2004; 12(2):11-22. PubMed ID: 15460563
    [No Abstract]   [Full Text] [Related]  

  • 8. The Global Forum for Bioethics in Research: report of a meeting.
    Loff B; Hofman K; Muthuswamy V
    Issues Med Ethics; 2001; 9(2):63-4. PubMed ID: 16334477
    [No Abstract]   [Full Text] [Related]  

  • 9. No double standards: scientists must obey the same ethical rules wherever they work.
    New Sci; 2002 Apr; 174(2340):3. PubMed ID: 12575727
    [No Abstract]   [Full Text] [Related]  

  • 10. A cultural understanding of research ethics governance.
    Brunger F; Burgess M
    Health Law Rev; 2005; 13(2-3):69-74. PubMed ID: 16459417
    [No Abstract]   [Full Text] [Related]  

  • 11. Standards for ethical publication.
    Johnson JT; Niparko JK; Levine PA; Kennedy DW; Rudy SF; Weber P; Weber RS; Benninger MS; Rosenfeld RM; Ruben RJ; Smith RJ; Sataloff RT; Weir N
    Am J Otolaryngol; 2007; 28(1):1-2. PubMed ID: 17162121
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical research, risk, and bystanders.
    Kimmelman J
    IRB; 2005; 27(4):1-6. PubMed ID: 16220627
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ethics of medical scientific research: informed consent and the therapeutic misconception].
    Rietsema C
    Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1495-6; author reply 1496. PubMed ID: 18668726
    [No Abstract]   [Full Text] [Related]  

  • 14. Professional responsibility and the protection of human subjects of research in Canada.
    Dinsdale H
    Health Law Rev; 2005; 13(2-3):80-5. PubMed ID: 16459419
    [No Abstract]   [Full Text] [Related]  

  • 15. Just-in-time IRB review: capitalizing on scientific merit review to improve human subjects research compliance.
    Kelly PA; Johnson ML
    IRB; 2005; 27(2):6-10. PubMed ID: 15948325
    [No Abstract]   [Full Text] [Related]  

  • 16. Human research ethics in practice: deliberative strategies, processes and perceptions.
    Gillam L; Guillemin M; Bolitho A; Rosenthal D
    Monash Bioeth Rev; 2009 Mar; 28(1):7.1-17. PubMed ID: 19839277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How not to rethink research ethics.
    Beauchamp TL
    Am J Bioeth; 2005; 5(1):31-3; author reply W15-8. PubMed ID: 16036653
    [No Abstract]   [Full Text] [Related]  

  • 18. Rethinking protections for human subjects.
    Gunsalus CK
    Chron High Educ; 2002 Nov; 49(12):B34. PubMed ID: 15287114
    [No Abstract]   [Full Text] [Related]  

  • 19. [The Tenovofir trial in Cameroun. Analysis of the controversial positions and proposal for an ethical alternative].
    Munday F; Lubangi G; Mukandu F; Leyens S
    Sante; 2006; 16(2):131-3. PubMed ID: 17180762
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessing benefits in clinical research: why diversity in benefit assessment can be risky.
    Churchill LR; Nelson DK; Henderson GE; King NM; Davis AM; Leahey E; Wilfond BS
    IRB; 2003; 25(3):1-8. PubMed ID: 14569987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.